AeroLeads people directory · profile
Rajeev Chillakuru Email & Phone Number
Co-Founder and CEO
at
CoFormBio
1 work email found
@eqrx.com
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Co-Founder and CEO
Location
Greater Boston, United States, United States
Company size
Who is Rajeev Chillakuru? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Rajeev Chillakuru is listed as Co-Founder and CEO at CoFormBio, a company with 2 employees, based in Greater Boston, United States, United States. AeroLeads shows a work email signal at eqrx.com and a matched LinkedIn profile for Rajeev Chillakuru.
Rajeev Chillakuru previously worked as Co-Founder & CEO at Stealth Mode Biotech and Founder and CEO at Stealth Proto-Biotech. Rajeev Chillakuru holds Post-Doctoral, Molecular Virology from University Of California, Davis.
Company email context
Email format at CoFormBio
This section adds company-level context without repeating Rajeev Chillakuru's masked contact details.
{first_initial}{last}@eqrx.com
86% confidence
AeroLeads found 1 current-domain work email signal for Rajeev Chillakuru. Compare company email patterns before reaching out.
Profile bio
About Rajeev Chillakuru
Ardent biopharmaceutical entrepreneur with a proven track record in biologics drug development from early R&D and product design stages through commercial launch, in building out and leading Preclinical R&D and Technical Operations/Pharmaceutical Sciences teams, in evaluating & negotiating in-licensed biologics drugs and successfully co-leading Series A/B fundraising Extensive multi-disciplinary leadership experience in biologics drug discovery & preclinical development, GLP/non-GLP pharmacology & toxicology, non-clinical/CMC regulatory strategy, Quality management systems (QMS), commercial cost of goods sold (COGS) analysis & supply chain management, product and portfolio IP strategy, and CRDO/CDMO contract negotiations and management.Proficient in building out high-throughput platforms for biologic drug candidate production & screening and complex biologic drug design & engineering, including bispecific antibodies, antibody drug conjugates and fusion proteinsEstablished cost-effective and fast-to-clinic antibody discovery & development platforms including lead candidate selection, antibody engineering, high-throughput functional/developability assays screens, non-clinical pharmacology & toxicology assessments and rapid CMC development/manufacturing for IND and post-IND submissionsCurrently raising seed funding for establishing a novel hub-and-spoke platform of biologic drugs:- Building a clinical stage company to rapidly establish a portfolio of highly-differentiated biologic drugs for auto-immune and inflammatory diseases- Setting up a company to establish oral delivery of validated biologics in human clinical studies
Listed skills include Technology Transfer, Protein Chemistry, Biopharmaceuticals, Biotechnology, and 49 others.
Current workplace
Rajeev Chillakuru's current company
Company context helps verify the profile and gives searchers a useful next step.
Coformbio
18 roles · 32 years
Rajeev Chillakuru work experience
A career timeline built from the work history available for this profile.
Co-Founder & Ceo
CurrentAs the Co-Founder & CEO of Stealth Mode Biotech in Greater Boston, I lead the strategic vision and execution of building a portfolio of innovative biologic drugs in immunology. By in-licensing clinically validated biologic drugs and modifying them for clinical and commercial differentiation, we aim to create novel drug products with brand-new IP and.
Jan 2024 - Present
Founder And Ceo
Current
Stealth Proto-Biotech
Concept stage company with focus on developing a proprietary oral delivery platform for biologic drugs. Evaluating potential peptides candidates for use with our patented formulation technology.
Dec 2023 - Present
Company Owner
Current
Biodrugs Llc
Responsible for antibody discovery and engineering, including antibody drug conjugates (ADCs) and bispecific antibodies, diligence & tech transfer for in-licensed biologics, CMC development & manufacturing and non-clinical regulatory strategy for IND-stage drugs
Feb 2023 - Present
Board Director
CurrentResponsible for developing novel biologics formulation technologies and managing the global growth strategy with a focus on North America
2017 - Present
~9 yrs 5 mos
Senior Vice President, Biologics
Eqrx International (Acquired By Revolution Medicines)
Responsible for antibody discovery and engineering, diligence & tech transfer for in-licensed biologics, non-clinical & CMC development, manufacturing, and regulatory licensure of EQRx’s biologic drugs
2020 - 2023
~3 yrs
Advisor
Responsible for advising early-stage companies on biologics development and CMC strategies.
2020 - 2022
~2 yrs
Technical Advisor
Led the pre-clinical and CMC development of lead product seribantumab
2019 - 2021
~2 yrs
Senior Vice President, Cmc & Nonclinical Development
Responsible for non-clinical safety/pharmacology and CMC development of Elstar’s complex multifunctional biologic drug candidates
2018 - 2020
~2 yrs
Vice President, Cmc
Responsible for Biologics and Small-Molecule CMC Development, cGMP manufacturing and Clinical Trial Materials supplies for all ongoing clinical studies
2017 - 2018
~1 yr
Head, Development Innovation/Msat, Biologics
Developed disruptive new continuous biomanufacturing process technologies for all biologics
2015 - 2016
~1 yr
Head, Manufacturing Strategy & Technical Services (Msat)
Responsible for establishing the manufacturing strategies and technical support for all of Dr. Reddy’s commercial biologics products, advancing new biologics through cGMP manufacturing and developing novel manufacturing process technologies
2014 - 2015
~1 yr
Vice President, Pharmaceutical Sciences (Virdante Pharmaceuticals, Acquired By Momenta)
Responsible for company start-up, Series A mezzanine fundraising and establishing a proprietary “sialic switch” technology platform for the development and manufacture of novel glyco-engineered biologic drugs for use in anti-inflammatory diseases
2008 - 2011
~3 yrs
Senior Director, Protein Sciences
Established the Biosimilar program at Momenta by building a cross-functional team of 30+ scientists to develop a unique glycoprotein characterization platform for complex biologics
2005 - 2008
~3 yrs
Executive Director, Bioprocess Development & Manufacturing
Successfully managed the FDA pre-approval inspection & licensure process and commercial launch of a therapeutic enzyme, Hylenex™, the only generic glycoprotein approved, to date, under the FDA’s 505(b)(2) pathway
2004 - 2005
~1 yr
Director, Bioprocess Development & Manufacturing
Spearheaded and implemented strategies for high-throughput novel biologics screening, fast-to-clinic bioprocess development platform, and GMP manufacturing of multiple biotherapeutic products in the product development portfolio:
1999 - 2004
~5 yrs
Director, Biomanufacturing
Responsible for contract management & execution, GMP manufacturing and GMP facility re-commissioning.
1997 - 1999
~2 yrs
Senior Scientist, Protein Sciences
Developed and established pre-clinical high-throughput production platforms for novel biologics screening, built out pilot and GMP manufacturing facilities and led the clinical manufacturing processes for multiple biologic candidates.
1994 - 1997
~3 yrs
2 education records
Rajeev Chillakuru education
Post-Doctoral, Molecular Virology
University Of California, Davis
Post-Graduate, Chemical Engineering
University At Buffalo
FAQ
Frequently asked questions about Rajeev Chillakuru
Quick answers generated from the profile data available on this page.
What company does Rajeev Chillakuru work for?
Rajeev Chillakuru works for CoFormBio.
What is Rajeev Chillakuru's role at CoFormBio?
Rajeev Chillakuru is listed as Co-Founder and CEO at CoFormBio.
What is Rajeev Chillakuru's email address?
AeroLeads has found 1 work email signal at @eqrx.com for Rajeev Chillakuru at CoFormBio.
Where is Rajeev Chillakuru based?
Rajeev Chillakuru is based in Greater Boston, United States, United States while working with CoFormBio.
What companies has Rajeev Chillakuru worked for?
Rajeev Chillakuru has worked for Coformbio, Stealth Mode Biotech, Stealth Proto-Biotech, Biodrugs Llc, and Bhami'S Research Laboratory Private Limited.
How can I contact Rajeev Chillakuru?
You can use AeroLeads to view verified contact signals for Rajeev Chillakuru at CoFormBio, including work email, phone, and LinkedIn data when available.
What schools did Rajeev Chillakuru attend?
Rajeev Chillakuru holds Post-Doctoral, Molecular Virology from University Of California, Davis.
What skills is Rajeev Chillakuru known for?
Rajeev Chillakuru is listed with skills including Technology Transfer, Protein Chemistry, Biopharmaceuticals, Biotechnology, Fda, Gmp, Protein Purification, and Biologics.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial